Introduction {#S0001}
============

Gastroesophageal reflux disease (GERD) is a chronic, recurrent disease commonly recognized in developed countries. The disease manifests itself with varying severity, from mild to incapacitating, with significant impairment of quality of life \[[@CIT0001]\]. For this reason, quality of life assessments are commonly used in conjunction with objective examinations in the evaluation of a treatment\'s efficacy relating to this disease \[[@CIT0002]\]. Interestingly, to a significant extent, the results of objective examinations are not always aligned with patient functioning, general well-being and treatment satisfaction \[[@CIT0003]\]. Despite a technically correct procedure and satisfactory objective examinations, some patients report a subpar outcome \[[@CIT0003]\]. Different authors have suspected different potential backgrounds to the latter phenomenon. Most pertain to the preoperative psychological status of the patient (e.g. depression) as being co-responsible for postoperative dissatisfaction with treatment \[[@CIT0004]\]. Therefore, quality of life assessment seems a valuable tool for outcome evaluation in GERD. It is worth mentioning that quality of life impairment due to GERD is more extensive than, for instance, due to diabetes, arterial hypertension or following myocardial infarction \[[@CIT0002]\].

Surgical treatment of GERD was widely introduced with the development of the laparoscopic approach, and the first laparoscopic anti-reflux procedure was performed in 1991 by Geagea \[[@CIT0005]\]. In several upper GI centers laparoscopic floppy Nissen fundoplication has been widely accepted as a gold standard \[[@CIT0006]\]. It has also been indicated as a first choice surgical treatment in the guidelines of both the European Association for Endoscopic Surgery and the Society of Gastrointestinal and Endoscopic Surgery \[[@CIT0007], [@CIT0008]\].

Typical symptoms of GERD are heartburn, regurgitation and dysphagia. One of the most commonly omitted symptoms during history taking is epigastric pain.

Aim {#S0002}
===

The aim of the study was to evaluate the dynamics of quality of life improvement after laparoscopic floppy Nissen fundoplication. The dynamics evaluated were the time sequence of symptom relief and improvement of quality of life. Moreover, it was aimed to assess severity of pain in patients suffering from GERD before and after laparoscopic floppy Nissen fundoplication.

Material and methods {#S0003}
====================

Material {#S20004}
--------

A data group of 104 consecutive patients with documented GERD who underwent operations between January 2004 and June 2008 in the Department of General, Endocrine and Transplant Surgery, Medical University of Gdansk, was prospectively analyzed. The study group consisted of 66 men and 38 women. Average age was 49 years (range: 23--75 years). In all patients laparoscopic floppy Nissen fundoplication was performed. Mesh repair was considered an exclusion criterion. The operating surgeons could be characterized as expert laparoscopists (with over 80 laparoscopic anti-reflux procedures performed each). The study was approved by the Local Independent Bioethical Committee at the Medical University of Gdansk.

Surgery and postoperative course {#S20005}
--------------------------------

The surgical procedure was performed in a standard manner, with liberation of the gastrosplenic ligament with LigaSure. Fundoplication was calibrated on a 10 mm laparoscopic Babcock placed as a probe between the stomach wall and fundoplication ring. Operating time did not exceed 150 min, with an average time of 62 min.

In the group of 104 patients, 32 complications or medical events were noted in a total of 21 patients. Seven patients were re-evaluated due to lack of improvement or symptom recurrence; of those aforementioned individuals, four underwent revision surgery. Fourteen patients presented to the emergency room because of dysphagia during the first 8 weeks following the operation. Twelve cases were successfully treated symptomatically. Two cases required endoscopic ballooning, which was performed with success. In 6 patients, CO~2~ subcutaneous emphysema or pneumothorax was observed, but lacked clinical significance. Umbilical port site infection was observed in four patients; umbilical hernia occurred in one of them.

Quality of life {#S20006}
---------------

Intensity of epigastric pain was analyzed at all follow-up meetings using the Visual Analogue Scale (VAS). The VAS is a scale ranging from 0 to 10, with 10 representing the highest imaginable pain and 0 representing no pain at all. Quality of life assessments were performed directly by a medical doctor in an outpatient clinic preoperatively as well as 1, 3, 6, 12 and 24 months after surgery. Quality of life was assessed using three questionnaires:

-   Functional Assessment of Chronic Illness Therapy, FACIT-G -- a 27-item Likert scale (scored with 0--108 points) intended for assessment of general health-related quality of life \[[@CIT0009], [@CIT0010]\]. It consists of four subscales: physical functioning, social and family functioning, emotional functioning, everyday functioning. FACIT-TS-G (treatment satisfaction -- general) is an eight-item Likert scale scored with 0-25 points designed for evaluation of patient satisfaction with treatment. Results of FACIT-G and FACIT-TS-G were represented as a percentage of the highest possible score (0--100%).

-   Gastrointestinal Quality of Life Index (GIQLI) -- recommended by the European Study Group for Antireflux Surgery for evaluation of quality of life related to gastrointestinal disease \[[@CIT0011]\]. GIQLI, a 36-item Likert scale, constitutes of five subscales: gastrointestinal symptoms, emotional status, physical functioning, social functioning and a single item that aims to assess treatment satisfaction. Scores range from 0 to 144 points.

-   DeMeester and Johnson GERD symptom scale -- a three-item Likert questionnaire assessing the main symptoms of GERD during the previous month, those symptoms being heartburn, regurgitation and dysphagia \[[@CIT0012]\]. Each symptom is scored from 0 to 3 points, corresponding to its severity. The total result may range from 0 to 9 points.

Duration of the disease was on average 6.54 ±7.96 years with duration of pain being 4.89 ±6.09 years. Return to full activity was observed, on average, in 8.21 weeks and resumption of work occurred after an average of 5.07 weeks. Follow-up efficiency was reported: at 1 month -- 89.42%, 3 months -- 80.69%, 6 months -- 74.04%, 12 months -- 68.27%, 24 months -- 53.85%. At 24 months after surgery, 14 patients (25%) reported occasional use of anti-secretory drugs with the mode value of one tablet per day.

Statistical analysis {#S20007}
--------------------

Statistical analysis was performed with Statistica 7.1 PL software. ANOVA and Fisher\'s post-hoc tests were used. Statistical significance was achieved when *p* value was less than 0.05.

Results {#S0008}
=======

Pain {#S20009}
----

The average pain score prior to surgical intervention, evaluated via the VAS scale, was 6.3 ±3.36 points. A statistically significant decrease of pain (40% reduction of preoperative values) was observed 3 months after surgery ([Table I](#T0001){ref-type="table"}).

###### 

Pain at follow-up points. Shaded values represent significant differences compared to preoperative assessment in post-hoc analysis

             PRE    1 M    3 M    6 M    12 M   24 M   ANOVA
  ---------- ------ ------ ------ ------ ------ ------ --------------
  **Pain**   6.34   6.03   3.84   4.08   4.19   4.31   *p* \< 0.001

Symptom relief and quality of life {#S20010}
----------------------------------

Gastroesophageal reflux disease symptoms, measured with the DeMeester and Johnson scale, improved significantly in the first month following surgery and remained at this level until 24 months after surgery ([Figure 1](#F0001){ref-type="fig"}).

![Total score in DeMeester and Johnson GERD symptom scale. ANOVA *p* \< 0.001. Posthoc *p* values given in table below graph](WIITM-10-25771-g001){#F0001}

More specifically, a notable improvement of heartburn and regurgitation could be observed 1 month after surgery. At 1 month following the surgical procedure, that is within the first post-operative follow-up period, a marked increase of dysphagia (*de novo*) was noticed ([Table II](#T0002){ref-type="table"}).

###### 

Three symptoms evaluated with the DeMeester and Johnson GERD symptom scale at follow-up points. Shaded values represent significant differences compared to preoperative assessment in post-hoc analysis

  Symptoms        PRE    1 M    3 M    6 M    12 M   24 M   ANOVA
  --------------- ------ ------ ------ ------ ------ ------ --------------
  Heartburn       1.94   0.64   0.52   0.47   0.48   0.80   *p* \< 0.001
  Regurgitation   1.50   0.27   0.44   0.27   0.57   0.55   *p* \< 0.001
  Dysphagia       0.48   1.36   0.52   0.40   0.70   0.60   *p* \< 0.001

Significant improvement in gastrointestinal quality of life (GIQLI) was found 3 months after surgery and remained at that level through the next 24 months ([Figure 2](#F0002){ref-type="fig"}). Significant improvement was observed at different points in time within all sub-scales. The main sub-scales responsible for notable enhancement of gastrointestinal quality of life were gastrointestinal symptoms and emotional status ([Table III](#T0003){ref-type="table"}).

![Total gastrointestinal quality of life (GIQLI) score. ANOVA *p* = 0.002. Post-hoc *p* values presented in table below graph](WIITM-10-25771-g002){#F0002}

###### 

Results in sub-scales of GIQLI. Shaded values represent significant differences compared to preoperative assessment in post-hoc analysis

  Sub-scales               PRE     1 M     3 M     6 M     12 M    24 M    ANOVA
  ------------------------ ------- ------- ------- ------- ------- ------- --------------
  GI symptoms              40.78   45.58   54.00   49.93   49.74   50.65   *p* = 0.001
  Physical functioning     14.32   16.50   16.23   16.67   17.57   17.95   *p* = 0.021
  Social functioning       10.70   10.92   13.08   12.33   13.17   12.20   *p* = 0.034
  Emotional status         10.49   11.33   14.58   12.93   14.39   15.65   *p* \< 0.001
  Treatment satisfaction   2.51    2.75    2.92    3.00    3.26    3.25    *p* = 0.021

Global quality of life measured with the FACIT-G questionnaire improved significantly 12 months after surgery ([Figure 3](#F0003){ref-type="fig"}). The sub-scales chiefly responsible for significant improvement within FACIT-G were physical functioning and everyday functioning ([Table IV](#T0004){ref-type="table"}).

![Total FACIT-G score. ANOVA *p* = 0.005. Post-hoc *p* values given in table below graph](WIITM-10-25771-g003){#F0003}

###### 

Results in sub-scales of FACIT-G. Shaded values represent significant differences compared to preoperative assessment in post-hoc analysis

  Sub-scales                      PRE     1 M     3 M     6 M     12 M    24 M    ANOVA
  ------------------------------- ------- ------- ------- ------- ------- ------- -------------
  Physical functioning            53.11   74.57   66.07   68.65   74.76   72.73   *p* = 0.018
  Everyday functioning            54.47   78.57   68.45   64.29   75.71   72.40   *p* = 0.037
  Social and family functioning   75.28   70.97   79.72   69.41   76.09   75.53   *p* = 0.779
  Emotional functioning           60.61   62.50   71.88   69.22   72.30   68.98   *p* = 0.327

Overall satisfaction with surgical treatment was high and did not change significantly during the observation period ([Figure 4](#F0004){ref-type="fig"}).

![FACIT-TS-G score at follow-up points. ANOVA *p* = 0.531. Post-hoc analysis -- no significant differences. By definition treatment satisfaction was not measured before surgery](WIITM-10-25771-g004){#F0004}

Discussion {#S0011}
==========

In this study we found that GERD is associated with significant epigastric pain and that quality of life improves significantly following laparoscopic floppy Nissen fundoplication. Moreover, we demonstrated that the dynamics of quality of life improvement are different for different aspects of quality of life.

Epigastric pain was observed in virtually all patients (92.31%) prior to surgery, and the duration of the pain was on average nearly 5 years. Pain in the epigastrium prior to surgery was scored with an average value of 6.34 on the VAS scale, which, according to the Kelly classification, is of moderate severity \[[@CIT0013]\]. Omission of this category and location of pain is not an uncommon practice in medical workups of patients with GERD. As mentioned in prior statements, surgical treatment with laparoscopic floppy Nissen fundoplication led to pain relief 3 months after the procedure. Upon the follow-up visit 1 month after surgery, it was found that pain remained at the level observed before the surgical procedure. This phenomenon is most likely a result of relief from GERD-associated discomfort in combination with increased epigastric pain related directly to the surgery itself. Abdominal pain and chest pain following laparoscopic fundoplication are reported in 24.0% and 19.5% of patients respectively. Pain was mild or moderate in the majority and severe in 4% of patients. Neither frequency nor severity of pain was associated with operation type \[[@CIT0014]\].

The possible role of central sensitization in delayed pain relief should be recognized \[[@CIT0015]\]. That is, hypersensitivity of the hypothalamus and cortex, caused by pain related to GERD in the preoperative period, can lead to misinterpretation of the stimuli in this region or aggravation of mild pain \[[@CIT0016]\]. Pain significantly decreases 3 months after surgery. At this follow-up point, relief of *de novo* dysphagia and improvement in gastrointestinal quality of life are also observed. These observations support our explanation based on the adjustment to changed hiatal anatomy.

Average duration of the disease was 6.54 years, similarly to that observed in other studies \[[@CIT0017], [@CIT0018]\]. Long duration of the illness and unsuccessful medical treatment in this group of patients can lead to psychological changes typical for chronic diseases \[[@CIT0019]\]. These changes are described in relation to several diseases such as rheumatoid diseases, psoriasis, chronic renal failure, asthma, chronic pancreatic pain, hyperhydrosis or obesity \[[@CIT0020]\]. Patients suffering from chronic ailments learn to live with the disease, and an immediate recovery, such as that witnessed with anti-reflux surgery, can paradoxically cause stress and engage new adaptation mechanisms. This, in and of itself, holds the possibility of impairment of quality of life \[[@CIT0019]\].

The preoperative average for the DeMeester and Johnson score was 3.94 points (on a scale from 0 to 9). Laparoscopic Nissen fundoplication leads to significant improvement in this symptom score as early as 1 month after surgery, an effect which remains throughout the observational period. The main symptoms found in the study group were heartburn and regurgitation; following surgical intervention, both of the these symptoms were relieved. Although relief of heartburn and regurgitation were noted, a significant increase in *de novo* dysphagia occurred. Dysphagia observed in the first 6--8 weeks after surgery is related to the operative technique and is a common finding. Investigations are necessary only if it maintains longer than this 6 to 8 week period. It also should be taken into account that subjective symptoms of dysphagia were proven not to correlate with manometric studies \[[@CIT0021]\]. In this study, early postoperative dysphagia at 1-month follow-up was a significant finding but diminished at further observation points. It was proven that the results of pHmetric examination along with the results of SI and QOL questionnaires can predict the outcome of GERD patients \[[@CIT0022]\].

Nissen fundoplication is a simple and effective approach for patients with gastroesophageal reflux symptoms due to diaphragmatic esophageal hiatal hernia -- it should be the method of choice in patients with type III and IV hernia \[[@CIT0023], [@CIT0024]\]. What is more, it is the method of choice in the treatment of Barrett\'s esophagus in the cases of patients who were qualified for surgery \[[@CIT0025]\].

Low-cost proton pump inhibitors (PPI) and laparoscopic Nissen fundoplication represent cost-effective treatment strategies. Procedural GERD therapy should be considered for patients who require high-dose or expensive PPIs \[[@CIT0026]\].

Quality of life in GERD patients is low, a fact which is confirmed by several authors \[[@CIT0002]\]. Low quality of life was demonstrated using different instruments involving SF-36 or GERD-HRQL questionnaires \[[@CIT0018]\]. In this study, global quality of life, measured with the FACIT-G questionnaire prior to the surgery, was on average 53.52% of the maximal value. In comparison, the score was 72% in conservatively treated patients with chronic pancreatitis who were examined in our center with the same questionnaire \[[@CIT0021]\]. Scores from 48% to 81% were reported in different chronic diseases \[[@CIT0027]\]. In this study significant improvement in global quality of life was observed as late as 12 months after surgery and remained at this level until the final observation point 24 months after surgery. Other authors reported significant improvement in quality of life as soon as 1 month after surgery \[[@CIT0018], [@CIT0028], [@CIT0029]\]. More than 90% of the patients would undergo the surgery again or recommend it \[[@CIT0030]\].

Rattner from Massachusetts Genral Hospital (MGH), using the Psychological and General Well Being Index (PGWB), presented improvement of global quality of life even sooner -- at 2 weeks after surgery \[[@CIT0031]\]. Considering GERD as a chronic disease, such late improvement in quality of life as that observed in our study after definitive treatment seems justified and likely from the psychological point of view. Patients suffering from long lasting GERD are well adapted to symptoms, limitations and problems related to the disease. Rapid or immediate improvement after anti-reflux surgery may result in invalidation of many, if not all defense and adaptive psychological mechanisms developed throughout the course of the disease. At the same time, new symptoms (e.g. *de novo* dysphagia, postoperative pain) create new psychological challenges. Thus it can be concluded that readaptation to the state of health takes 12 months in this study group. Such a long period of adjustment may appear in response to a fear of loss of secondary benefits, for instance increased social support (family and friends) and lack of a factor that perhaps justifies life\'s failures. This may factor into the explanation of why symptom relief in GERD patients does not immediately cause improvement in quality of life but rather is co-dependent on psychological re-adaptation to the new health condition.

Treatment satisfaction and quality of life evaluation could, apart from objective outcome measures, be incorporated in routine patient evaluation. Objective parameters often poorly describe patients' everyday functioning \[[@CIT0032]\]. Moreover, 2 persons with the same pathology can respond completely differently to correction of the problem due to personality, coexisting depressive disorders and environmental or social factors \[[@CIT0004], [@CIT0033]--[@CIT0035]\]. In this study, treatment satisfaction measured with the FACIT-TS-G questionnaire 1 month after surgery was high, reaching 78%. This level was observed throughout the study, with fluctuations between 66.89% and 83.14%. Satisfaction with the treatment was also measured using the GIQLI questionnaire (based on a single item). It was seen to increase from the first month after surgery, reaching significance (81% when converted to percentage of maximum values) 12 and 24 months following intervention. Similar satisfaction with laparoscopic treatment of GERD was observed by other authors \[[@CIT0036], [@CIT0037]\]. In a large study from MGH based on 405 patients operated on for GERD, 71% of the patients were satisfied with the surgical treatment \[[@CIT0036]\]. Doctor-patient communication and interaction were proven to be of high importance for satisfaction of the patient with symptomatic treatment of GERD \[[@CIT0038]\]. It can be anticipated that in surgical treatment of GERD a similar influence exists. Kamoltz proved that psychological intervention in some patients can result in significant improvement of quality of life and decrease symptom severity \[[@CIT0004]\]. This fact confirms the observations of this study that relief of symptoms does not directly translate into improvement of global quality of life and suggests that surgery alone is an incomplete form of therapy.

For assessment of gastrointestinal quality of life the GIQLI questionnaire was used; it is the most commonly used instrument for measuring quality of life in gastrointestinal pathologies. The average score in the healthy population is 122.6 ±8.5 points \[[@CIT0011]\]. In this study group, the score was 82.15 points for preoperative assessment and is comparable with other authors \[[@CIT0005]\]. Pointer *et al*. reported 87 points, Slim *et al*. reported 95.6 points, and Ciovica *et al*. reported 86 points \[[@CIT0005]\].

Gastrointestinal quality of life, measured with the GIQLI questionnaire, significantly improved 3 months after surgery. This effect was sustained until the last observation point, that is, 24 months after surgical intervention. This result finds itself between symptom improvement on the DeMeester and Johnson GERD scale (at 1 month) and improvement in the general quality of life in FACIT-G assessment (at the twelfth month). Similarly, in a study by Dallemagne using the GIQLI questionnaire in GERD patients, postoperative improvement was observed in the total GIQLI score and the sub-scales gastrointestinal symptoms and emotional status \[[@CIT0039]\]. In a report from Zell am See, improvement was recognized in the total GIQLI score and all sub-scales. The total GIQLI score after 3 months reached the level of the healthy population and remained at that level for the following 3 years of observation \[[@CIT0038]\].

Efficiency and competency of follow-up procedures in this study can be considered a certain weakness of this study. However, it was performed with direct contact between doctor and patient, which by itself could improve patient satisfaction. Efficiency ranged from 89.42% 1 month after surgery to 53.85% in the twenty-fourth month after surgery. In a study on quality of life after anti-reflux surgery, published by Woodcock *et al*., follow-up was executed at identical time intervals but by phone \[[@CIT0003]\]. Subsequently, patients were sent questionnaires by mail and were asked to return the questionnaires, following completion, to the investigators. This methodology resulted in a lower response rate, from 40% to 65% at different time points.

In summary, GERD is a chronic disease of long duration, leading to impairment of quality of life. Patients, apart from typical symptoms of GERD, suffer from pain of significant severity. Surgical treatment -- laparoscopic Nissen fundoplication -- leads to improvement of quality of life, although not reaching healthy population levels. Symptom relief and quality of life improvement exhibit varying and individual dynamics ([Figure 5](#F0005){ref-type="fig"}). Relief from heartburn and regurgitation is observed 1 month after surgery and remains at that level throughout the 24-month observation period. Improvement of gastrointestinal quality of life is observed with a 3-month delay after the surgical procedure. Global quality of life improves significantly 12 months after surgery. Increasingly ameliorated quality of life was accompanied with high, constant satisfaction with treatment from the first month after surgery.

![Schematic demonstration of dynamics of quality of life improvement (with pain and symptom relief) after laparoscopic floppy Nissen fundoplication](WIITM-10-25771-g005){#F0005}

Conclusions {#S0012}
===========

Quality of life is an important quality measure of surgery for GERD. Quality of life improvement is gradual, from GERD-specific symptoms to global quality of life. It is an important finding for the patients to ensure realistic expectations and for the doctors to develop an adequate follow-up schedule.
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